Peter Zimetbaum

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

Nicholas J. Mercuro, Christina Yen, David Shim et al. · JAMA Cardiology · 2020 · 717 citations · Full text

Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction

Paul Sorajja, Bernard J. Gersh, DA Cox et al. · European Heart Journal · 2007 · 521 citations · Full text

Treatment of Obstructive Sleep Apnea Reduces the Risk of Atrial Fibrillation Recurrence After Catheter Ablation

Adam S. Fein, Alexei Shvilkin, Dhaval Shah et al. · Journal of the American College of Cardiology · 2013 · 433 citations

Sleep, Catheter Ablation, Cardiac Anaesthesia +9

Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States

Karin S. Coyne, Clark Paramore, Susan Grandy et al. · Value in Health · 2006 · 425 citations · Full text

Health Policy, Health Economics, Cardiovascular Disease +13

Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device

Mintu P. Turakhia, Donald D. Hoang, Peter Zimetbaum et al. · The American Journal of Cardiology · 2013 · 253 citations · Full text